The intersection between philosophy and psychedelics is explored in the book “Philosophy and Psychedelics: Frameworks for Exceptional Experience”. The authors aim to develop a dialogue between the two disciplines and explore the various frameworks for understanding exceptional experiences that psychedelics have afforded human beings. The book delves into foundational, ontological, and epistemological questions, including the hard problem of consciousness, the metaphysical understanding of the self, and the aesthetic meaning of the sublime in psychedelic experience. The book provides valuable exploration of questions concerning prevailing metaphysical frameworks, epistemic belief structures, and modes of inquiry, and the effort made by the authors to bring into dialogue multiple dialectics and practices, perspectives and methods is commendable.
{"title":"Philosophy and psychedelics: Frameworks for exceptional experience","authors":"T. Dowie, Julien Tempone-Wiltshire","doi":"10.1556/2054.2023.00283","DOIUrl":"https://doi.org/10.1556/2054.2023.00283","url":null,"abstract":"The intersection between philosophy and psychedelics is explored in the book “Philosophy and Psychedelics: Frameworks for Exceptional Experience”. The authors aim to develop a dialogue between the two disciplines and explore the various frameworks for understanding exceptional experiences that psychedelics have afforded human beings. The book delves into foundational, ontological, and epistemological questions, including the hard problem of consciousness, the metaphysical understanding of the self, and the aesthetic meaning of the sublime in psychedelic experience. The book provides valuable exploration of questions concerning prevailing metaphysical frameworks, epistemic belief structures, and modes of inquiry, and the effort made by the authors to bring into dialogue multiple dialectics and practices, perspectives and methods is commendable.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44908463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
B. Labate, A. Ermakova, Jordan Sloshower, N. Galvão-Coelho, Fernanda Palhano-Fontes, Henrique Fernandes Antunes, Glauber Loures de Assis, Clancy Cavnar, D. D. de Araujo, S. Ribeiro
On February 2023, the Drug Enforcement Administration (DEA) released a document to the legal team representing the Church of the Eagle and the Condor (“CEC”). This disclosure came two years after the church, in conjunction with Chacruna Institute, submitted two FOIA requests to the DEA and the Department of Justice requesting all records pertaining to ayahuasca. This report, titled “Ayahuasca: Risks to Public Health and Safety,” was issued in July 2020. In the present article, we challenge a number of claims made in the DEA report and highlight significant factual omissions, theoretical biases, and misinterpretations of existing data. We will demonstrate that the DEA report severely downplays the safety profile and therapeutic potential of ayahuasca and overemphasizes the risks. It also fails to include current research on ayahuasca demonstrating its potential benefits.
{"title":"The DEA report on ayahuasca risks: “Science” in service of prohibition?","authors":"B. Labate, A. Ermakova, Jordan Sloshower, N. Galvão-Coelho, Fernanda Palhano-Fontes, Henrique Fernandes Antunes, Glauber Loures de Assis, Clancy Cavnar, D. D. de Araujo, S. Ribeiro","doi":"10.1556/2054.2023.00279","DOIUrl":"https://doi.org/10.1556/2054.2023.00279","url":null,"abstract":"On February 2023, the Drug Enforcement Administration (DEA) released a document to the legal team representing the Church of the Eagle and the Condor (“CEC”). This disclosure came two years after the church, in conjunction with Chacruna Institute, submitted two FOIA requests to the DEA and the Department of Justice requesting all records pertaining to ayahuasca. This report, titled “Ayahuasca: Risks to Public Health and Safety,” was issued in July 2020. In the present article, we challenge a number of claims made in the DEA report and highlight significant factual omissions, theoretical biases, and misinterpretations of existing data. We will demonstrate that the DEA report severely downplays the safety profile and therapeutic potential of ayahuasca and overemphasizes the risks. It also fails to include current research on ayahuasca demonstrating its potential benefits.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42011534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Ten years of Psychedemia — and the future","authors":"Emma Stamm","doi":"10.1556/2054.2023.00272","DOIUrl":"https://doi.org/10.1556/2054.2023.00272","url":null,"abstract":"","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47403370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Despite recent research linking lifetime classic psychedelic use to positive mental health outcomes, little work has explored the role played by classic psychedelics in healthy users' ability to cope with ordinary, yet stressful, life situations.This study begins to fill this gap by exploring whether lifetime classic psychedelic use is associated with attenuated or exacerbated psychological distress in unemployed job seekers.Drawing on openly-available data from the National Survey on Drug Use and Health (2013–2019) on 208,136 adults in the United States, this study tests whether lifetime classic psychedelic use interacts with employment status to predict differences in respondents' psychological distress experienced in the last 30 days.After adjusting for sociodemographics, health factors, and other substance use, unemployed job seekers with lifetime classic psychedelic use are found to report greater psychological distress relative to unemployed job seekers without lifetime psychedelic use. No differences in psychological distress based on lifetime classic psychedelic use were found in employed individuals.This study suggests that lifetime classic psychedelic use (of indoleamines specifically) may exacerbate stressful phases of life and provides context to previous studies linking lifetime classic psychedelic use to predominantly positive mental health outcomes in healthy populations.This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Furthermore, the author declares that there is no conflict of interest.
{"title":"Lifetime classic psychedelic use is associated with greater psychological distress in unemployed job seekers","authors":"Benjamin A. Korman","doi":"10.1556/2054.2023.00246","DOIUrl":"https://doi.org/10.1556/2054.2023.00246","url":null,"abstract":"Despite recent research linking lifetime classic psychedelic use to positive mental health outcomes, little work has explored the role played by classic psychedelics in healthy users' ability to cope with ordinary, yet stressful, life situations.This study begins to fill this gap by exploring whether lifetime classic psychedelic use is associated with attenuated or exacerbated psychological distress in unemployed job seekers.Drawing on openly-available data from the National Survey on Drug Use and Health (2013–2019) on 208,136 adults in the United States, this study tests whether lifetime classic psychedelic use interacts with employment status to predict differences in respondents' psychological distress experienced in the last 30 days.After adjusting for sociodemographics, health factors, and other substance use, unemployed job seekers with lifetime classic psychedelic use are found to report greater psychological distress relative to unemployed job seekers without lifetime psychedelic use. No differences in psychological distress based on lifetime classic psychedelic use were found in employed individuals.This study suggests that lifetime classic psychedelic use (of indoleamines specifically) may exacerbate stressful phases of life and provides context to previous studies linking lifetime classic psychedelic use to predominantly positive mental health outcomes in healthy populations.This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Furthermore, the author declares that there is no conflict of interest.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49656032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Although numerous cultures have used psychoactive substances for spiritual, or entheogenic, purposes, little is known about contemporary entheogenic spirituality, particularly outside of the few traditions that retain sacramental drug use practices.To better conceptualize contemporary patterns of entheogenic drug use, an international, online study of entheogenic drug users was conducted (n = 684). Hierarchical regression analysis was used to explore entheogenic drug use in relation to measures of spiritual seeking (importance of spirituality in life, mediation practice, openness to experience), self-transcendent experiences (awe-proneness, mystical experiences), psychological well-being (psychological distress, subjective and eudaimonic well-being), and psychospiritual development (quiet ego, self-transcendence/wisdom, and spiritual development). ANOVA was used to compare entheogenic drug users with non-entheogenic drug users and non-drug users to assess differences across these psychospiritual variables.Of the 12 drug categories assessed, the classic psychedelics were most commonly used as entheogens. Entheogenic classic psychedelic use was associated with all of the assessed psychospiritual variables; entheogenic classic psychedelic users showed higher levels of spiritual seeking, self-transcendence, psychological well-being, and psychospiritual development compared to non-entheogenic classic psychedelic users and non-users.Entheogenic spirituality may be conceptualized as a practice of spiritual seeking or implicit mysticism–the quest for self-transcendence and personal growth.
{"title":"Entheogens and spiritual seeking: The quest for self-transcendence, psychological well-being, and psychospiritual growth","authors":"K. O. St. Arnaud, D. Sharpe","doi":"10.1556/2054.2023.00263","DOIUrl":"https://doi.org/10.1556/2054.2023.00263","url":null,"abstract":"Although numerous cultures have used psychoactive substances for spiritual, or entheogenic, purposes, little is known about contemporary entheogenic spirituality, particularly outside of the few traditions that retain sacramental drug use practices.To better conceptualize contemporary patterns of entheogenic drug use, an international, online study of entheogenic drug users was conducted (n = 684). Hierarchical regression analysis was used to explore entheogenic drug use in relation to measures of spiritual seeking (importance of spirituality in life, mediation practice, openness to experience), self-transcendent experiences (awe-proneness, mystical experiences), psychological well-being (psychological distress, subjective and eudaimonic well-being), and psychospiritual development (quiet ego, self-transcendence/wisdom, and spiritual development). ANOVA was used to compare entheogenic drug users with non-entheogenic drug users and non-drug users to assess differences across these psychospiritual variables.Of the 12 drug categories assessed, the classic psychedelics were most commonly used as entheogens. Entheogenic classic psychedelic use was associated with all of the assessed psychospiritual variables; entheogenic classic psychedelic users showed higher levels of spiritual seeking, self-transcendence, psychological well-being, and psychospiritual development compared to non-entheogenic classic psychedelic users and non-users.Entheogenic spirituality may be conceptualized as a practice of spiritual seeking or implicit mysticism–the quest for self-transcendence and personal growth.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41645897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Whether occasioned through careful, consistent meditative practice or through quicker means like the ritual ingestion of psilocybin or ayahuasca, global contemplative practices have established effective systems of implementing, directing, and integrating the very kinds of non-ordinary experiences central to psychedelic use. However, contemplative traditions are largely absent from the present discourse on psychedelic therapy. This paper addresses this gap and offers a novel analysis of psychedelic-assisted therapy through the lens of the Tibetan Buddhist contemplative tradition. It first establishes a baseline for comparing the non-ordinary experience occasioned by Tibetan Buddhist meditation and the psychedelic experience by referencing the phenomenological literature of both. It then articulates the Tibetan contemplative framework of view, meditation, action (Tib. lta sgom spyod gsum) as the way Tibetan Buddhism directs its non-ordinary meditative experience towards its desired ends and suggests how this framework may be applied to psychedelic-assisted therapy. Finally, this paper uses this Tibetan Buddhist lens of analysis to compare and assess two protocols for psychedelic-assisted therapy and to make recommendations for future clinical protocols. Given the phenomenological similarity of Tibetan Buddhist meditative experience and the psychedelic experience, this article suggests that a more intensive preparatory session where maladaptive conceptual narratives are worked through and beneficial ones are introduced, repeated dosing sessions, and a more directed psychedelic experience may increase the efficacy of psychedelic-assisted therapy. It thus argues that the insights of the Tibetan framework of view, meditation, action can improve future protocols and allow for psychedelic-assisted therapy to be of even greater benefit.
{"title":"View, meditation, action: A Tibetan framework to inform psychedelic-assisted therapy","authors":"Colin H. Simonds","doi":"10.1556/2054.2023.00255","DOIUrl":"https://doi.org/10.1556/2054.2023.00255","url":null,"abstract":"Whether occasioned through careful, consistent meditative practice or through quicker means like the ritual ingestion of psilocybin or ayahuasca, global contemplative practices have established effective systems of implementing, directing, and integrating the very kinds of non-ordinary experiences central to psychedelic use. However, contemplative traditions are largely absent from the present discourse on psychedelic therapy. This paper addresses this gap and offers a novel analysis of psychedelic-assisted therapy through the lens of the Tibetan Buddhist contemplative tradition. It first establishes a baseline for comparing the non-ordinary experience occasioned by Tibetan Buddhist meditation and the psychedelic experience by referencing the phenomenological literature of both. It then articulates the Tibetan contemplative framework of view, meditation, action (Tib. lta sgom spyod gsum) as the way Tibetan Buddhism directs its non-ordinary meditative experience towards its desired ends and suggests how this framework may be applied to psychedelic-assisted therapy. Finally, this paper uses this Tibetan Buddhist lens of analysis to compare and assess two protocols for psychedelic-assisted therapy and to make recommendations for future clinical protocols. Given the phenomenological similarity of Tibetan Buddhist meditative experience and the psychedelic experience, this article suggests that a more intensive preparatory session where maladaptive conceptual narratives are worked through and beneficial ones are introduced, repeated dosing sessions, and a more directed psychedelic experience may increase the efficacy of psychedelic-assisted therapy. It thus argues that the insights of the Tibetan framework of view, meditation, action can improve future protocols and allow for psychedelic-assisted therapy to be of even greater benefit.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41910411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ingestion or administration of classic psychedelics is sometimes associated with improvements in well-being or mental health. Acute mystical-type experiences that psychedelics occasion have been suggested to be related to such improvements. Meanwhile, other features of the psychedelic experience, such as psychological insights and emotional breakthroughs, are also increasingly being studied. This review aimed to collect and assess the available evidence for mystical-type experiences under psychedelics associating with medium-to-long term improvements in well-being or mental health, on their own and as compared with other features of the acute experience.I conducted a pre-registered, comprehensive review of existing empirical studies on the topic, based on a systematic search of the literature.Forty-four eligible studies were found, with most reporting positive associations between mystical-type experiences and improvements in well-being or mental health. The current level of evidence appeared stronger among healthy people, in cross-sectional studies, and for links with positive changes in general well-being and life satisfaction, attitudes and behavior, and anxiety, than for depression or other aspects of well-being and mental health. A few studies suggested that psychological insights and emotional breakthroughs may be as or more closely associated with positive changes than mystical-type experiences.Despite their significant limitations, the identified studies suggest that mystical-type experiences under psychedelics are associated with improvements in some areas of well-being. However, psychological insights and emotional breakthroughs might be at least as important and should also be measured in future studies.
{"title":"Association between mystical-type experiences under psychedelics and improvements in well-being or mental health – A comprehensive review of the evidence","authors":"Samuli Kangaslampi","doi":"10.1556/2054.2023.00243","DOIUrl":"https://doi.org/10.1556/2054.2023.00243","url":null,"abstract":"Ingestion or administration of classic psychedelics is sometimes associated with improvements in well-being or mental health. Acute mystical-type experiences that psychedelics occasion have been suggested to be related to such improvements. Meanwhile, other features of the psychedelic experience, such as psychological insights and emotional breakthroughs, are also increasingly being studied. This review aimed to collect and assess the available evidence for mystical-type experiences under psychedelics associating with medium-to-long term improvements in well-being or mental health, on their own and as compared with other features of the acute experience.I conducted a pre-registered, comprehensive review of existing empirical studies on the topic, based on a systematic search of the literature.Forty-four eligible studies were found, with most reporting positive associations between mystical-type experiences and improvements in well-being or mental health. The current level of evidence appeared stronger among healthy people, in cross-sectional studies, and for links with positive changes in general well-being and life satisfaction, attitudes and behavior, and anxiety, than for depression or other aspects of well-being and mental health. A few studies suggested that psychological insights and emotional breakthroughs may be as or more closely associated with positive changes than mystical-type experiences.Despite their significant limitations, the identified studies suggest that mystical-type experiences under psychedelics are associated with improvements in some areas of well-being. However, psychological insights and emotional breakthroughs might be at least as important and should also be measured in future studies.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44028380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This paper aims at presenting an overview of the historic and current features concerning the relationship among original peoples, psychoactive drugs, and various forms of anti-drug practices in Latin America. The current expansion of extractivist capitalism in Latin America overlaps with Indigenous peoples' traditional lands, provoking new forms of violence and confrontation. The War on Drugs is being used as a justification to militarize these lands and to criminalize Indigenous populations. Thus, neo-extractivist initiatives in Latin America provoke renewed clashes between Indigenous peoples' interests and local and global elites' purposes. We seek to raise awareness about the relationship between the drug war and Indigenous people's human rights violations as an alert and an invitation for social scientists to engage in theoretical and empirical research on this issue.
{"title":"The impacts of the drug war on Indigenous Peoples in Latin America: An overview","authors":"B. Labate, Thiago Rodrigues","doi":"10.1556/2054.2023.00239","DOIUrl":"https://doi.org/10.1556/2054.2023.00239","url":null,"abstract":"This paper aims at presenting an overview of the historic and current features concerning the relationship among original peoples, psychoactive drugs, and various forms of anti-drug practices in Latin America. The current expansion of extractivist capitalism in Latin America overlaps with Indigenous peoples' traditional lands, provoking new forms of violence and confrontation. The War on Drugs is being used as a justification to militarize these lands and to criminalize Indigenous populations. Thus, neo-extractivist initiatives in Latin America provoke renewed clashes between Indigenous peoples' interests and local and global elites' purposes. We seek to raise awareness about the relationship between the drug war and Indigenous people's human rights violations as an alert and an invitation for social scientists to engage in theoretical and empirical research on this issue.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67001256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Riley D. Kirk, Olivia M. Uhley, Paloma Lehfeldt, C. Shields, M. Garretson, Alanna Collins, H. Wahbeh, S. Dahmer
Entheogen use is becoming increasingly popular and a potential option for treatment or adjuvant treatment for various medical conditions. Clinical studies are needed to determine the efficacy, safety, and possible role of these traditional medicines in the context of modern society and the Western medicine paradigm. The willingness of patients to participate in such studies is currently unknown.In September 2021 we implemented an anonymous, observational pilot survey to determine the general public's willingness to participate in future entheogen research. All participants were English-speaking adults and had participated in therapy or a retreat utilizing entheogens in a naturalistic setting in the last five (5) years. Participants were recruited through community outreach via email.The response rate for this data set was estimated to be 48.3% (n = 84/174). Nearly all (95.5%) participants believed this research should be done and 86.9% said they would participate in entheogen research that lasted longer than one year. A greater proportion of participants were willing to participate in remote interviews (73.5%) rather than in-person surveys (64.7%). A majority of participants (78%) also noted the importance of financial compensation for their time influencing the willingness to participate in future entheogen studies.The willingness to participate in research involving traditional entheogens is not the limiting factor in facilitating further studies. Participants held overwhelmingly positive perceptions indicating that they believed this research should be done. Future longitudinal clinical studies with financial compensation and controlled set and settings will be necessary to expand the evidence base for naturalistic entheogen use.
{"title":"Willingness to participate in entheogen use research in naturalistic settings","authors":"Riley D. Kirk, Olivia M. Uhley, Paloma Lehfeldt, C. Shields, M. Garretson, Alanna Collins, H. Wahbeh, S. Dahmer","doi":"10.1556/2054.2022.00238","DOIUrl":"https://doi.org/10.1556/2054.2022.00238","url":null,"abstract":"Entheogen use is becoming increasingly popular and a potential option for treatment or adjuvant treatment for various medical conditions. Clinical studies are needed to determine the efficacy, safety, and possible role of these traditional medicines in the context of modern society and the Western medicine paradigm. The willingness of patients to participate in such studies is currently unknown.In September 2021 we implemented an anonymous, observational pilot survey to determine the general public's willingness to participate in future entheogen research. All participants were English-speaking adults and had participated in therapy or a retreat utilizing entheogens in a naturalistic setting in the last five (5) years. Participants were recruited through community outreach via email.The response rate for this data set was estimated to be 48.3% (n = 84/174). Nearly all (95.5%) participants believed this research should be done and 86.9% said they would participate in entheogen research that lasted longer than one year. A greater proportion of participants were willing to participate in remote interviews (73.5%) rather than in-person surveys (64.7%). A majority of participants (78%) also noted the importance of financial compensation for their time influencing the willingness to participate in future entheogen studies.The willingness to participate in research involving traditional entheogens is not the limiting factor in facilitating further studies. Participants held overwhelmingly positive perceptions indicating that they believed this research should be done. Future longitudinal clinical studies with financial compensation and controlled set and settings will be necessary to expand the evidence base for naturalistic entheogen use.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48325632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Coinciding with and responding to a growing crisis in the diagnostic, explanatory and treatment systems of psychiatry, the last couple of decades have seen a growing amount of evidence regarding the therapeutic potential of psychedelic drugs to treat a variety of mental health conditions. Broadly, this crisis can be construed as that of “indivi/dualist” approaches which aim to treat patients who are construed as separated from their social and material contexts, which are taken as given. The implicit premise: the self, but not the world, is the site of therapeutic intervention. By contrast, researchers insist that psychedelic therapy functions by on producing an experience of “connectedness” to self, world, and others, which is heavily influenced by context. However, by remaining in an indivi/dualist thoughtspace, neurological and psychological perspectives betray these recurring themes. In this essay, I approach psychedelic therapy for depression through the lens of phenomenological psychiatry to take these themes seriously–a task which passes by considering experience as embodied, and therefore embedded. Starting off from an analysis of depression as a bodily detunement (disconnection), I argue that, through a process of “immersive reflection”, psychedelic therapy transforms not only the self, but patients’ sense of reality. This will allow me to answer several questions pertaining to psychedelic therapy regarding its therapeutic mechanism, why it transforms reality and not only the self, why it transforms and not merely amplifies experience, why its effects last beyond the drugs’ psychoactive duration, and in what their paradigm-shifting potential for mental health consists of.
{"title":"Psychedelic therapy as reality transformation: A phenomenological approach","authors":"Mateo Sanchez Petrement","doi":"10.1556/2054.2023.00231","DOIUrl":"https://doi.org/10.1556/2054.2023.00231","url":null,"abstract":"Coinciding with and responding to a growing crisis in the diagnostic, explanatory and treatment systems of psychiatry, the last couple of decades have seen a growing amount of evidence regarding the therapeutic potential of psychedelic drugs to treat a variety of mental health conditions. Broadly, this crisis can be construed as that of “indivi/dualist” approaches which aim to treat patients who are construed as separated from their social and material contexts, which are taken as given. The implicit premise: the self, but not the world, is the site of therapeutic intervention. By contrast, researchers insist that psychedelic therapy functions by on producing an experience of “connectedness” to self, world, and others, which is heavily influenced by context. However, by remaining in an indivi/dualist thoughtspace, neurological and psychological perspectives betray these recurring themes. In this essay, I approach psychedelic therapy for depression through the lens of phenomenological psychiatry to take these themes seriously–a task which passes by considering experience as embodied, and therefore embedded. Starting off from an analysis of depression as a bodily detunement (disconnection), I argue that, through a process of “immersive reflection”, psychedelic therapy transforms not only the self, but patients’ sense of reality. This will allow me to answer several questions pertaining to psychedelic therapy regarding its therapeutic mechanism, why it transforms reality and not only the self, why it transforms and not merely amplifies experience, why its effects last beyond the drugs’ psychoactive duration, and in what their paradigm-shifting potential for mental health consists of.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44748250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：